trihexyphenidyl has been researched along with Chronic Hepatitis C in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cocco, GA | 1 |
| Loudianos, G | 1 |
| Pes, GM | 1 |
| Tolu, F | 1 |
| Lepori, MB | 1 |
| Barrocu, M | 1 |
| Sechi, GP | 1 |
1 other study available for trihexyphenidyl and Chronic Hepatitis C
| Article | Year |
|---|---|
"Acquired" hepatocerebral degeneration in a patient heterozygote carrier for a novel mutation in ATP7B gene.
Topics: Adenosine Triphosphatases; Adult; Amino Acid Substitution; Basal Ganglia; Cation Transport Proteins; | 2009 |